These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 5611712)

  • 1. [On the use of beta-adrenoreceptor blocking agents in patients with coronary insufficiency with disorders of heart rhythm].
    Anshelevich IuV; Gol'dberg TO; Beer ET
    Ter Arkh; 1967 Sep; 39(9):98-100. PubMed ID: 5611712
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new beta blocking agent: LB-46. Clinical use in the treatment of rhythm disorders and coronary insufficiency].
    Dutoit A; Lepoutre B; Leuridan B; Croccel L; Giard P
    J Sci Med Lille; 1972 Feb; 90(2):83-9. PubMed ID: 4403207
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experience with preparation LB-46 in various rhythm disorders and ischemic heart disease].
    De La Hoz Fabra J; Pérez Casar F; Carillo Kabana J
    Rev Esp Cardiol; 1970; 23(1):76-99. PubMed ID: 4393269
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical evaluation of the effects of beta-adrenergic blocking in heart diseases, with special reference to disorders of rhythm and circulation].
    Fassini G; Saurgnani E; Agliati G; Marangoni R
    Minerva Cardioangiol; 1967 Jan; 15(1):83-122. PubMed ID: 4386133
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical evaluation of the beta-adrenergic blocking action of butydrine].
    Nigro G; Comi LI; Limongelli F
    Minerva Cardioangiol; 1968 Dec; 16(12):1267-72. PubMed ID: 5752613
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of an adrenergic beta-receptor blocking agent in coronary insufficiency and heart rhythm disorders].
    Doshchitsyn VL
    Kardiologiia; 1966; 6(5):65-9. PubMed ID: 6000275
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preliminary clinical observations on the anti-arrhythmic action of a new beta-receptor blocking agent: propranolol].
    Cherchi A; Lixi M; Mazza B; Camoglio E
    Minerva Med; 1966 Jan; 57(9):317-27. PubMed ID: 5909139
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recent acquisitions on beta blocking agents].
    Lesbre JP; Mériel P; Baledent M
    Therapeutique; 1971 Nov; 47(9):797-9. PubMed ID: 4401847
    [No Abstract]   [Full Text] [Related]  

  • 9. Contribution to the clinical evaluation of beta-adrenergic blocking drugs: 1-p-nitrophenyl-2-isopropylaminoethanol (INPEA) as an antagonist of catecholamines in normal persons and in coronary disease patients.
    Piva M; Ongari R
    Arzneimittelforschung; 1968 Feb; 18(2):179-88. PubMed ID: 5695376
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic use of beta-adrenergic blocking agents].
    Renner C; Rouffy J
    Presse Med (1893); 1967 Jul; 75(32):1651-3. PubMed ID: 6027505
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy with beta-blocking agents in cardiology].
    Dal Palù C
    Minerva Med; 1970 Nov; 61(95):5450-8. PubMed ID: 4395227
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical data on 20 patients treated with the association of butydrine and pentaerythritol tetranitrate].
    Rossi PL; Guarraggi A; Anfossi F
    Clin Ter; 1971 May; 57(4):345-50. PubMed ID: 5110948
    [No Abstract]   [Full Text] [Related]  

  • 13. [Beta-blocking drugs in cardiac therapy].
    Pretolani E
    G Clin Med; 1968 Feb; 49(2):221-8. PubMed ID: 4392710
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of coronary insufficiency with beta-adrenergic blocking agents in association with a nitroderivative].
    Rinaldi AR; Zanacchi G
    Minerva Cardioangiol; 1971 Mar; 19(3):160-71. PubMed ID: 4396512
    [No Abstract]   [Full Text] [Related]  

  • 15. Proceedings: Clinical evaluation of perhexiline maleate in the treatment of chronic cardiac arrhythmias of patients with coronary heart disease.
    Sukerman M
    Postgrad Med J; 1973 Apr; 49():Suppl 3:46-52. PubMed ID: 4587032
    [No Abstract]   [Full Text] [Related]  

  • 16. [Beta-blocking drugs in coronary insufficiency. Clinical experiences with iproveratril].
    Guadagno L; Giannelli G; Ghiara F; Guadagno P; Zucchelli GP
    Minerva Med; 1967 Sep; 58(77):3288-94. PubMed ID: 6054782
    [No Abstract]   [Full Text] [Related]  

  • 17. [Beta adrenergic blocking agents in Chagasic heart disease].
    Plotquin Y; Abrahim HC
    Prensa Med Argent; 1968 Oct; 55(35):1725-30. PubMed ID: 4977209
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experience with the use of sodium hydroxybutyrate in patients with acute coronary insufficiency and cardiac rhythm disorders].
    Popov VG; Kharkevich DA; Syrkin AL; Basistov AF; Lazebnik LB; Lazutin VK
    Ter Arkh; 1968 Dec; 40(12):44-7. PubMed ID: 5746542
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action of propranolol, beta-adrenergic blocking agent, on disorders of cardiac rhythm].
    Sánchez A; Cárdenas M; Shapiro M
    Arch Inst Cardiol Mex; 1967; 37(1):47-62. PubMed ID: 6058090
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of pindolol (LB 46), a new beta-blockader in disorders of cardiac rhythm].
    Poletti T; Aquaro G
    Minerva Cardioangiol; 1972; 20(7):402-18. PubMed ID: 4403233
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.